The Effects of Allopurinol on Levels of Cardiac Troponin Following Non-ST Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial
Background: Given the potential anti-ischemic effects of allopurinol, we aimed to assess whether allopurinol administration may reduce myocardial injury following non-ST elevation myocardial infarction (NSTEMI). Methods: A randomized clinical trial (RCT) was conducted on 100 individuals with NSTEMI....
Main Authors: | Sajad Khiali, Parvin Sarbakhsh, Sina Mashayekhi, Elham Mohamadrezapour, Samaneh Dousti, Taher Entezari-Maleki |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2021-12-01
|
Series: | Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://ps.tbzmed.ac.ir/PDF/ps-27-560.pdf |
Similar Items
-
Evaluating the effects of empagliflozin in preventing myocardial injury in patients undergoing percutaneous coronary intervention: A double-blind, randomized clinical trial
by: Hossein Behzad, et al.
Published: (2024-06-01) -
Effects of Allopurinol in the Prevention of Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention: A Randomized Clinical Trial
by: Naser Aslanabadi, et al.
Published: (2024-01-01) -
Allopurinol
by: 982 SIRIM -
Features of hemostasis in patients with non-ST-elevation myocardial infarction
by: Mihail Popovici, et al.
Published: (2022-09-01) -
Early versus late intervention in patients with high-risk non-‘ST’-elevation myocardial infarction
by: Emmanuel Louka Aziz, et al.
Published: (2022-01-01)